The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
CORONARY INTERVENTIONS
Evaluating the importance of sham-controlled trials in the investigation of medical devices in interventional cardiology
EuroIntervention 2018;14:708-715 published online May 2018. DOI: 10.4244/EIJ-D-18-00481
Robert A. Byrne1, MD; Davide Capodanno2, MD, PhD; Felix Mahfoud3,4, MD; Jean Fajadet5, MD; Stephan Windecker6, MD; Peter Jüni7, MD; Andreas Baumbach8, MD, FESC; William Wijns9, MD, PhD; Michael Haude10*, MD, PhD
1. Deutsches Herzzentrum München, Technische Universität München, Munich, Germany; 2. Division of Cardiology, CAST, P.O. “Rodolico”, Azienda Ospedaliero-Universitaria “Policlinico-Vittorio Emanuele”, University of Catania, Catania, Italy; 3. Department of
Cardiovascular medicine is one of the specialties that has relied most heavily on evidence from randomised clinical trials in determining best practice for the management of common disease conditions. When comparing treatment